Daily Derm Times: April 29, 2025

To stay up-to-date with the latest dermatology news, sign up to receive our eNewsletters.

Subgroup Case Series Reveals JAKi Efficacy for Black Patients With AA

JAK inhibitors show promise in treating alopecia areata among Black patients, highlighting the need for inclusive clinical research and equitable access to therapies.

FDA Approves First Gene Therapy for RDEB

The FDA approved pz-cel, a groundbreaking gene therapy for recessive dystrophic epidermolysis bullosa, transforming treatment options for patients.

Newly Developed Questionnaire Evaluates Quality of Life for Patients with Hair and Scalp Conditions

The innovative 21-item Hair & Scalp CARE questionnaire is designed to evaluate the psychological impact of hair and scalp conditions on quality of life.

Interview Intersection: Expert Interviews From April 2025

Dermatology Times is recapping our exclusive expert interviews from the month of April.

How Does Psoriasis Influence Sun Tanning Addiction?

Younger patients with moderate to severe psoriasis exhibit risky sun exposure behaviors, raising concerns about tanning addiction and skin cancer risks.

Understanding the Role of OX40 in Next-Generation Eczema Therapies

Acting upstream of cytokines may hold the key to improving biologic efficacy and itch relief in AD.